Extensive inflammation of actinic keratoses during interferon α therapy for chronic hepatitis C in a Taiwanese albino woman-Reference-Cited by-同舟云学术

Extensive inflammation of actinic keratoses during interferon α therapy for chronic hepatitis C in a Taiwanese albino woman

Published:2013-11 Issue:11 Volume:112 Page:728-729
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Yang Wei-Li,Lee Julia Yu-Yun

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma;Sung;J Gastroenterol Hepatol,1997

2. Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy;Kuo;J Formos Med Assoc,2011

3. Inflammation of actinic keratoses from systemic chemotherapy;Johnson;J Am Acad Dermatol,1987

4. An oncology patient with an erythematous papulosquamous eruption in sun-exposed areas. Inflamed actinic keratoses due to systemic chemotherapy (fluorouracil and, possibly, interferon alfa);Sollitto;Arch Dermatol,1994

5. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”;Wenzel;J Invest Dermatol,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer;Scientific Reports;2018-08-28

2. Emerging treatments for chronic hepatitis C;Journal of the Formosan Medical Association;2015-03

3. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C;Journal of the Formosan Medical Association;2014-12

4. A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin;Journal of the Formosan Medical Association;2014-10

5. Peginterferon-α-2b;Reactions Weekly;2014-02